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Abstract: Alterations in protein glycosylation play an
important role in patho-physiology, and much effort has
been devoted to detecting glycoprotein biomarkers. In this
manuscript, we describe the development of a novel
method for monitoring alterations in protein glycosyla-
tion. Lectins are used as individual affinity reagents and
coupled to magnetic beads (Dynabeads) in a microplate
array format for isolation of glycosylated proteins. Isolated
glycoproteins are digested with trypsin in-solution fol-
lowed by LC-MS/MS, allowing a liquid handler-assisted
high throughput workflow. We demonstrate the specific
and reproducible affinity-isolation of glycoproteins using
the lectin Dynabead array technology. When used with
serum, we achieved one-step purification of glycoproteins
with minimal coisolation of abundant serum proteins
including albumin. We further optimized the proteomics
workflow to allow transfer to a liquid handler for automa-
tion. In summary, we report the development of a high
throughput platform to detect alterations in protein gly-
cosylation which will be useful in glycoproteomics stud-
ies, particularly clinical proteomics studies where large
sample sizes are required to achieve statistical power.
Keywords: biomarker discovery • serum proteomics •
glycosylation • cancer • lectin • magnetic beads
Introduction
The study of glycans (glycomics) and glycosylated proteins
(glycoproteomics) has become a leading area of biomarker
discovery activities in recent years.1-5 Lectins, naturally oc-
curring proteins that preferentially bind specific glycan moi-
eties, are well-used research tools in glycoprotein studies. As
early as the 1980s, lectin-coupled beads were used to capture
glycoproteins.6 Lectin immunohistochemistry was used to
demonstrate altered glycosylation in breast cancer,7 and more
recently, lectin-affinity chromatography has been used in
combination with mass spectrometry to examine the glyco-
proteome of pancreatic, breast, liver and colorectal cancer using
serum, plasma or cells as sample source.8-12 These studies
demonstrate the utility and feasibility of lectin-affinity isolation-
coupled proteomics as a means of identifying glycoproteins.
These studies have used relatively small sample sizes, partly
due to the high level of sample handling. To achieve statistical
power for clinical proteomics studies, and to distinguish
between different states of glycosylation, we set out to establish
a high throughput platform using lectins as monoaffinity
reagents. In this Technical Note, we report the development a
proteomics workflow using lectin-coupled magnetic beads, in-
solution digest and LC-MS/MS for isolation and identification
of serum glycoproteins. This workflow achieved a one-step
purification of serum glycoproteins, removing the need for
depletion, separation or cleanup steps. Importantly, we show
that protein binding to lectin-magnetic beads is lectin-selective
and highly reproducible.
Experimental Section
Reagents.MyOne and M280 magnetic Dynabeads were from
Life Technologies (Dynal). Lectins and lectin-coupled agarose
beads were purchased from Vector Laboratories. Modified
sequencing grade bovine trypsin was from Promega. All other
reagents were from Sigma unless otherwise specified.
Patient Sample. Blood samples were collected with consent
and ethics approval by the Study of Digestive Health (Queen-
sland Institute for Medical Research) and accessed with ap-
proval by University of Queensland Human Ethics Committee.
Sera were stored in aliquots at -80 °C.
Preparation and Use of Lectin-Dynabeads. Lectin coupling
to surface-activated Dynabeads was performed according to
manufacturer’s protocol, and the beads were then blocked with
1 M Tris buffer pH 7.5 for 16 hours. Lectin-Dynabeads were
washed 3 times with binding buffer containing 20 mM Tris/
HCl pH 7.4, 15 mMNaCl, 1 mM CaCl2, 1 mMMnCl2, (1% Triton
X-100, 0.2% SDS, 1 mM DTT where indicated) and protease
inhibitors (1 µg/µL Aprotinin, 1 µg/µL Antipain, 1 µg/µL
Pepstatin, 1 µg/µL Leupeptin and 2.5 mM Benzamidine).
Protein sample (2 µL of serum) was incubated with lectin-
coupled beads diluted in binding buffer as specified and rotated
at 4 °C for 30 min. After glycoprotein capture, beads were
washed three times with 10 volumes of binding buffer. Protein
elution methods depended on subsequent analysis. For 2D gel
electrophoresis, proteins were eluted with 2D sample buffer
(7 M urea, 2 M thiourea, 4% CHAPS, 100 mM DTT 0.5%
ampholyte 3-10, trace bromophenol blue) for 30 min at room
temperature prior to rehydrating pH 3-11, nonlinear, 7 cm
Immobilzed pH gradient strips (GE healthcare). Isoelectric
point focusing was performed using the OffGel Fractionator
(Agilent) programmed for total of 8 kVh, limited at 5000 V, 50
µA, 200mW and 5 h. After equilibration with 2% DTT and then
2.5% IAA in equilibration buffer (6 M urea, 375 mM Tris/HCl
pH 8.8, 2% SDS, 20% glycerol), strips were placed on top of
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10%mini-SDS-PAGE gels and subjected to electrophoresis. Gels
were stained with colloidal coomassie.13 In-gel digest was
performed as previously described.14
For direct in-solution digest and LC-MS/MS, beads were
additionally washed twice with 200 mM Tris/HCl pH 7.4, twice
with 50 mM NH4HCO3, then the proteins were eluted with one
volume of 50% formic acid followed by one volume of 20%
acetonitrile. The formic acid in the eluate was neutralized with
two volumes of 50 mM NH4HCO3. The samples were dried in
a speedy vac, resuspended in 20 µL of NH4HCO3 and digested
with 0.5 µg trypsin (Promega sequencing grade modified bovine
trypsin) overnight at 37 °C. Trypsin was inactivated by acidi-
fication to 5% formic acid. Samples were dried in a speedy vac
and resuspended in 40 µL of 5% formic acid.
LC-MS/MS. Tryptic peptides corresponding to 5% of lectin-
Dynabead pulldown (approximately 1 µg of protein from 2 µL
of starting serum) were subjected to LC-MS/MS using an
Agilent 6520 QTOF coupled with a Chip CUBE and 1200 HPLC.
The nano pump was set at 0.3 µL/min and the capillary pump
at 4 µL/min. The HPLC-chip used contained a 40nl C18
trapping column, and a 150 mm C18 resolving column (Agi-
lent). Buffer A was 0.1% formic acid and buffer B was 0.1%
formic acid in 90% acetonitrile. For in-solution digest, the
gradient went from 10% to 50% Buffer B in 45 min, and then
95% Buffer B at 46 min, returning to 10% buffer B at 50 min.
For 2D gel spots, the gradient went from 10% to 50% Buffer B
in 20 min, and then 95% Buffer B at 20.10 min, returning to
10% buffer B at 22.10 min. The mass spectrometer was
programmed to acquire 8 precursor MS1 spectra per minute
and 4 MS/MS spectra per minute. Dynamic exclusion was
applied after 2 MS/MS within 0.25 min. Results were searched
against IPI human v3.64 database using SpectrumMill (Agilent
A03.03). The following parameters were used for search: 2
maximum missed cleavage, precursor mass tolerance of (20
and product mass tolerance of (50. For 2D spots and when
testing reduction/alkylation in solution, carbamidomethylation
was selected as fixed modification.
Safety Considerations. Some lectins can be mitogenic or
cytotoxic, material safety datasheet should be consulted for
each lectin and appropriate personnel protective equipment
used.
Results and Discussion
In order to achieve sample throughput for clinical proteom-
ics studies, we wished to establish a high throughput autom-
atable procedure that links protein isolation/separation to mass
spectrometry. Magnetic beads are easily adaptable to robotic
liquid handlers and thus represent the support of choice when
considering high throughput affinity isolation procedures. Since
our affinity reagents, lectins, are proteins, we examined the
functionalized Dynabeads that were recommended for direct
protein coupling, namely epoxy, tosyl and carboxylic acid
activated Dynabeads (LifeTechnologies, Dynal). Preliminary
results suggest that epoxy and tosyl-activated beads are better
than carboxylic beads at capturing wheat germ agglutinin (data
not shown), therefore we further compared the coupling
efficiency of tosyl and epoxy activated beads with commercial
agarose beads (Vector Laboratories) for Concanavalin A (ConA),
wheat germ agglutinin (WGA) and Jacalin (JAC), with visualiza-
tion by colloidal Coomassie staining. Tosyl-activated beads
captured the highest level of lectin, as judged by coomassie
staining (Figure 1). We selected 1 µm diameter MyOne tosyl-
activated beads (Life Technologies Dynal) for use in further
experiments because the small diameter of the beads offers
more surface area for protein capture.
Initial experiments comparing the ability of lectin magnetic
beads to isolate glycoproteins from serum with commercial
lectin agarose beads showed comparable results (data not
shown), suggesting that lectin magnetic beads will be suitable
for glycoprotein isolation. One important consideration in lectin
pull down experiments is the possibility of isolating protein
complexes, leading to the erranous assignment of nonglyco-
sylated proteins, or glycoprotein with other glycan moieties.
Thus the use of binding buffer should be carefully considered
to reduce the presence of protein complexes, while retaining
lectin-glycan interactions. To this end, we compared pull down
using ConA-tosyl-activated Dynabeads under four different
binding buffers. Condition 1 used a lectin binding buffer from
Yang and Hancock15 that contained 20 mM Tris/HCl pH 7.4,
150 mMNaCl, 1 mM CaCl2, 1 mMMnCl2, with additional 0.05%
Triton X-100, and protease inhibitors as described in Experi-
mental Section. This represents a mild buffer condition with
minimal salt and detergent. This buffer was used during
binding and washing steps. In condition 2, we included 0.5 M
urea as denaturing agent in the base buffer in the binding and
washing steps to disrupt protein complexes. In condition 3,
additional 1 mM DTT, 0.2% SDS, and 1% Triton-X100 was
included in the wash buffer to increase the stringency of the
washing step. In the most stringent condition, the additional
DTT, SDS and Triton-X100 was included in both the binding
and wash buffers (condition 4). Since this condition contained
reducing agent and strong detergent during the entire pull
down, it was possible that lectin binding efficiency will be
reduced. After washing in binding buffer, bound proteins were
eluted in 2D sample buffer and analyzed by 2D gel electro-
phoresis with 2D standards loaded with each sample (Figure
2). Compared to input serum, the ConA-Dynabead pulldown
showed no visible albumin spot, demonstrating the selectivity
of the pulldown. Similar number of spots was observed in all
four conditions, with the numbers being 60, 57, 46, 50 spots
for conditions 1-4, respectively. While the inclusion of reducing
agent and strong detergent in binding and washing steps
(condition 4) resulted in ∼20% loss of protein binding, we still
Figure 1. Comparison of binding efficiency of Concanavalin A
(ConA), Jacalin (JAC) and wheat germ agglutinin (WGA) to
agarose and Dynabeads. Each lectin was bound to epoxy and
tosyl activated magnetic beads to the same concentration as
commercial agarose beads (ConA 6 mg/mL, Jac 4 mg/mL, WGA
7 mg/mL). Lectins were eluted from 2 µL of beads and examined
on 17% SDS-PAGE and colloidal coomassie staining.
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observed close to 50 spots, demonstrating the strong affinity
between lectin and their cognate glycans.
Sixty spots were excised from gel 1, subjected to in-gel tryptic
digest and LC-MS/MS. Fifty-two spots were positively identi-
fied (Figure 3, protein identification table available as Supple-
mentary Table 1, Supporting Information), with several proteins
identified in multiple spots giving a final of 31 proteins. Eight
spots were unidentified, either due to low abundance or the
intrinsic interference of highly modified peptides by LC-MS/
MS identification. The latter cause may be resolved by glycosi-
dase treatment of samples. Out of the 31 ConA-isolated
proteins, 18 proteins were annotated in UniProt as glycosylated
(Supplementary Table 1, Supporting Information). Several of
the other 13 ConA-isolated proteins were uncharacterized
sequences, while some were likely cobinding proteins such as
albumin. Further work using these beads may lead to identi-
fication of novel glycosylation sites. The most stringent condi-
tion, condition 4 was used in later experiments to prevent
isolation of nonglycoproteins using the ConA magnetic beads.
To develop a high throughput workflow, we wished to
perform in-solution tryptic digest of the isolated proteins, and
to directly inject sample to LC-MS/MS without clean up. To
this end, we specifically investigated two steps in the workflow.
First, we compared reduction/alkylation and clean up of the
Figure 2. Pulldown of serum proteins using ConA-Dynabeads.Glycoproteins were isolated from control patient serum (2 mL) using
Con A-coupled tosyl-activated magnetic beads using four different buffer conditions frommild (condition 1) to most stringent (condition
4) as described in Results and Discussion. Bound proteins were eluted in 2D sample buffer and analyzed by 2D electrophoresis and
colloidal coomassie staining, together with 2D standard. A 0.2 µL aliquot of the input serum is analyzed in (B) for comparison.
Figure 3. LC-MS/MS identification of ConA-Dynabead-binding serum proteins. 2D gel spots were excised, digested with trypsin and
subjected to LC-MS/MS analysis as detailed in Experimental Section.
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in-solution digest (the “standard” nonhigh throughput work-
flow) with a shortened protocol that leaves out these steps. After
washing the pulldown in binding buffer, and further washing
in 50 mM NH4HCO3, bound proteins were sequentially eluted
with 50% formic acid and 20% acetonitrile. After drying in a
speedvac, the samples were divided into two workflows. For
one set, proteins were reduced, alkylated, digested with trypsin
and then cleaned up with a C18 STAGE-tip.16 For the second
set, proteins were directly digested without reduction alkylation.
This experiment was designed to test if a shortened in-solution
digest procedure without reduction/alkylation produces ac-
ceptable number of protein identifications. Peptides were
analyzed by LC-MS/MS and database searching. Three techni-
cal replicates were performed. A protein identity was consid-
ered safe if it was identified in 2 out of the 3 replicates
(Supplementary Table 2, Supporting Information). Based on
these criteria, 50 proteins were identified from ConA-Dynabead
pulldowns using in-solution digest without reduction/alkylation
and clean up, in contrast to only 24 identified when reduction/
alkylation and STAGE-tip clean up was performed (Figure 4,
Supplementary Table 2, Supporting Information). The reduced
number of protein identified in the second protocol may be
due to significant sample loss during the clean up step. Analysis
by of similar pulldown 2D gel and in-gel digest had identified
31 proteins (Figure 3, Supplementary Table 1, Supporting
Information). When the overlap between the 3 protein iden-
tification procedures were compared, we found that 14 proteins
were identified by all 3 methods, while 22 proteins were
identified only using solution digest without reduction/alky-
lation. The 2D gel protocol identified 9 proteins that were not
found using solution digest. However, the entire pulldown was
loaded onto a single 2D gel, while only 5% of the sample was
loaded on the LC-MS/MS from the solution digest procedures,
suggesting a much reduced rate of protein identification with
2D gel separation. Based on these results, we selected in-
solution digest without reduction/alkylation as the protein
processing method prior to LC-MS/MS.
As our aim is to develop a liquid handler-assisted high
throughput workflow, we next examined if the entire procedure
performs as efficiently in 96 well microplates. For this experi-
ment, we divided ConA-Dynabeads into 6 aliquots, one set in
3 separate eppendorf tubes and one set in 3 wells of a 96 well
microplate. Pulldown was performed from aliquots of a single
serum sample, using a hand-held 96 well microplate bar
magnet (Life Technologies) for the microplate samples. All
samples were processed in parallel using in-solution digest
without reduction/alkylation, and analyzed by LC-MS/MS.
Protein identities were confirmed if 2 out of the 3 technical
replicates identified the protein. Surprisingly, we found that
performing the procedure in 96 well microplates actually
identified slightly more proteins, and the scores for protein
identification were also better with microplates (Figure 5,
Supplementary Table 3, Supporting Information). The majority
proteins were identified in both vessel formats, supporting the
consistency of the lectin-Dynabead pulldown workflow. We
analyzed the reproducibility between the 3 technical replicates
for the tube and microplate workflows. Protein identities were
highly reproducible in both microplate and tube workflows,
with the majority of proteins identified in all 3 technical
replicates (Figure 6, Supplemental Table 3, Supporting Infor-
mation). These results suggest that transferring the lectin-
Dynabead pulldown workflow to microplates will not reduce
efficiency but may in fact enhance the sensitivity and confi-
dence of protein identifications.
Figure 4. Number of proteins identified from ConA-Dynabeads
pulldown from serum. Overlap between serum proteins isolated
using ConA-Dynabeads were subjected to in-solution digest with
or without reduction, alkylation and STAGE-tip clean up, or
analyzed by 2D gel and in-gel digest of spots.
Figure 5. Comparison of tube versus microplate performace for
lectin-Dynabead pulldown coupled to in-solution digest and
LC-MS/MS.
Table 1. Selectivity of Lectin Magnetic Bead Pulldowna
known target ConA Jac SBA SNA STA UEA I WGA
R-Man, R-Glc, and R-GlcNAc ConA 53 16 5 38 19 8 20
GalR1-6GalNAc and Gal1-3GalNAc Jac 49 6 17 8 5 9
GalNAcR1-3Gal SBA 8 4 5 10 4
Neu5AcR2-6Gal and Neu5AcR2-6GalNAc SNA 53 22 10 20
GlcNAc1-4GlcNAc oligomers STA 36 10 21
FucR1-2Gal1-4GlcNAc UEA I 13 9
Neu5Ac and GlcNAc1-4GlcNAc WGA 31
a An array of seven lectin-coupled tosyl-activated beads was prepared and used to isolate serum glycoproteins from a single patient serum. Proteins
were eluted, digested in-solution and analysed by LC-MS/MS. The table shows the known glycan target of each lectin, and the number of overlapping
proteins identified between pairs of lectin pulldowns. Protein identification table is available as Supplementary Table 4 (Supporting Information).
Abbreviations: Fuc, fucose; Gal, galactose; GalNAc, N-Acetylgalactosamine; Glc, glucose; GlcNAc, N-Acetylglucosamine; Man, mannose; Neu5Ac,
N-acetylneuraminic acid (also called sialic acid); ConA, concanavalin A; Jac, Jacalin; SBA, Soy Bean Agglutinin (Glycine max lectin); SNA, Sambucus Nigra
Agglutinin; STA, Solanum Tuberosum Agglutinin; UEA I, Ulex Europaeus agglutinin I; WGA, wheat Germ agglutinin.
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To demonstrate the utility and selectivity of lectin-Dynabead
array, we prepared a panel of 7 lectin-Dynabeads and used this
small array in a pulldown experiment. The lectins were selected
based on their reported glycan affinities, covering both N- and
O-glycosylation as well as sialic acid modification (Table 1).
When aliquots of a single serum sample were subjected to
pulldown using this panel of lectin-Dynabeads, we observed
selective binding of proteins to the lectin-Dynabeads (Table 1,
Supplementary Table 4, Supporting Information). Most identi-
fied proteins bound to several lectins, reflecting the fact that
glycoproteins are often modified with multiple types and sites
of glycosylation. Table 1 shows the number of proteins isolated
by each lectin, and the number that is identified in pulldown
from pairs of lectin-Dynabeads. ConA and SNA (Sambucus
nigra Agglutinin) bound the highest number of proteins, with
more than 50% of the proteins in common. These may indicate
that ConA and SNA have similar binding specificities, or the
target glycans preferentially occur together. Glycomic analysis
of the isolated proteins will be required to further characterize
the glycan modifications. In contrast to ConA and SNA, which
have broad target specificity, SBA (Soy Bean Agglutinin) has a
narrow glycan selectivity, and only 8 proteins were isolated by
SBA-Dynabeads (Table 1). Thus, by combining lectin-Dynabead
array with bioinformatic analysis of the protein (and peptide/
glycan) identifications, this workflow has the potential to
identify alterations in glycosylation profiles due to disease.
Conclusions
We have developed a novel high throughput technique for
biomarker discovery and glycoproteomics studies. This method
is based on the use of lectin-Dynabeadsto isolate glycoproteins
in a glycan-specific manner. The increased throughput means
that many lectins can be tested per sample, and alterations in
lectin binding ability can be determined for many biological
samples. The utility of lectin magnetic beads as a one-step
serum glycoprotein isolation procedure will greatly assist
identification of serum biomarkers. Development of glycomic
analysis workflows combined with bioinformatic and biostatis-
tic analysis algorithms will be required to fully utilize this
technology for biomarker discovery.
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Figure 6. Reproducibility of lectin Dynabead pulldown. ConA-
coupled magnetic beads was used to isolate serum glycopro-
teins, which were eluted, digested in-solution and identified by
LC-MS/MS. The Venn diagram shows the reproducibility of the
procedure over 3 independent technical repeats when used with
(A) Eppendorf tubes and (B) 96-well microplates.
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